# Flanigans Enterprises Inc: overview BDL · NYSE · CIK 12040 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Oct 3 Pages: [Overview](/companies/bdl.md) · [Financials](/companies/bdl/financials.md) · [Filings](/companies/bdl/filings.md) · [Insiders](/companies/bdl/insiders.md) Latest reported revenue: [$56.2m](/filings/0001174947-26-000790.md) for Q3 FY2026, three months to 2026-06-27, from the 10-Q filed Aug 11, 2026 (XBRL us-gaap:Revenues, accession 0001174947-26-000790). ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [45.7](/filings/0001174947-25-001463.md) | [50.0](/filings/0001174947-26-000150.md) | [53.4](/filings/0001174947-26-000581.md) | [51.9](/filings/0001174947-26-000790.md) | [50.0](/filings/0001174947-25-001463.md) | [52.6](/filings/0001174947-26-000150.md) | [56.5](/filings/0001174947-26-000581.md) | [56.2](/filings/0001174947-26-000790.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [1.1%](/filings/0001174947-25-001463.md) | [1.5%](/filings/0001174947-26-000150.md) | [6.6%](/filings/0001174947-26-000581.md) | [5.5%](/filings/0001174947-26-000790.md) | [3.3%](/filings/0001174947-25-001463.md) | [3.2%](/filings/0001174947-26-000150.md) | [7.4%](/filings/0001174947-26-000581.md) | [7.1%](/filings/0001174947-26-000790.md) | | Net margin | % | [0.4%](/filings/0001174947-25-001463.md) | [0.1%](/filings/0001174947-26-000150.md) | [5.0%](/filings/0001174947-26-000581.md) | [2.7%](/filings/0001174947-26-000790.md) | [1.8%](/filings/0001174947-25-001463.md) | [1.5%](/filings/0001174947-26-000150.md) | [5.1%](/filings/0001174947-26-000581.md) | [3.7%](/filings/0001174947-26-000790.md) | | Diluted EPS | $ per share | [0.10](/filings/0001174947-25-001463.md) | [0.03](/filings/0001174947-26-000150.md) | [1.45](/filings/0001174947-26-000581.md) | [0.75](/filings/0001174947-26-000790.md) | [0.48](/filings/0001174947-25-001463.md) | [0.43](/filings/0001174947-26-000150.md) | [1.55](/filings/0001174947-26-000581.md) | [1.11](/filings/0001174947-26-000790.md) | | Free cash flow | $m | [0.4 d](/filings/0001174947-25-001463.md) | [7.0](/filings/0001174947-26-000150.md) | [(3.0) d](/filings/0001174947-26-000581.md) | [(1.8) d](/filings/0001174947-26-000790.md) | [2.4 d](/filings/0001174947-25-001463.md) | [4.5](/filings/0001174947-26-000150.md) | [1.3 d](/filings/0001174947-26-000581.md) | [(3.5) d](/filings/0001174947-26-000790.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-10-02) | FY2022 (2022-10-01) | FY2023 (2023-09-30) | FY2024 (2024-09-28) | FY2025 (2025-09-27) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [137](/filings/0001174947-23-000017.md) | [158](/filings/0001174947-23-001489.md) | [174](/filings/0001174947-24-001397.md) | [187](/filings/0001174947-25-001463.md) | [205](/filings/0001174947-25-001463.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [6.3%](/filings/0001174947-23-000017.md) | [4.4%](/filings/0001174947-23-001489.md) | [4.0%](/filings/0001174947-24-001397.md) | [3.1%](/filings/0001174947-25-001463.md) | [4.3%](/filings/0001174947-25-001463.md) | | Net margin | % | [8.6%](/filings/0001174947-23-000017.md) | [4.0%](/filings/0001174947-23-001489.md) | [2.3%](/filings/0001174947-24-001397.md) | [1.8%](/filings/0001174947-25-001463.md) | [2.5%](/filings/0001174947-25-001463.md) | | Diluted EPS | $ per share | [6.34](/filings/0001174947-23-000017.md) | [3.40](/filings/0001174947-23-001489.md) | [2.15](/filings/0001174947-24-001397.md) | [1.81](/filings/0001174947-25-001463.md) | [2.71](/filings/0001174947-25-001463.md) | | Free cash flow | $m | [7.5](/filings/0001174947-23-000017.md) | [6.5](/filings/0001174947-23-001489.md) | [(4.7)](/filings/0001174947-24-001397.md) | [3.2](/filings/0001174947-25-001463.md) | [4.7](/filings/0001174947-25-001463.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bdl/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $2.9m | 63,747 | | Unchanged | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $1.4m | 30,993 | | Reduced −500 | | [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $1.4m | 30,666 | | Reduced −5,000 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $909.7k | 20,287 | | Unchanged | | [Empowered Funds, LLC](/funds/1592828.md) | 2026-06-30 | $672.9k | 15,007 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $302.1k | 6,735 | | New +6,735 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $213.5k | 4,762 | | Added +1 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $134.1k | 2,991 | | Unchanged | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $63.4k | 1,414 | | Added +445 | | [Grove Bank & Trust](/funds/1662212.md) | 2026-06-30 | $14.3k | 320 | | New +320 | ## Recent filings [All 178 filings](/companies/bdl/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-11 | 15:51 ET | [10-Q](/filings/0001174947-26-000790.md) | Quarterly report, period 2026-06-27 | 0001174947-26-000790 | | 2026-05-12 | 12:13 ET | [10-Q](/filings/0001174947-26-000581.md) | Quarterly report, period 2026-03-28 | 0001174947-26-000581 | | 2026-03-02 | 15:16 ET | [8-K](/filings/0001174947-26-000239.md) | 5.07 Shareholder vote results | 0001174947-26-000239 | | 2026-02-10 | 15:29 ET | [10-Q](/filings/0001174947-26-000150.md) | Quarterly report, period 2025-12-27 | 0001174947-26-000150 | | 2026-01-23 | 13:17 ET | [DEF 14A](/filings/0001174947-26-000076.md) | Proxy statement, period 2026-02-27 | 0001174947-26-000076 | | 2026-01-12 | 15:00 ET | [8-K](/filings/0001174947-26-000032.md) | 5.02 Departure or appointment of officers or directors | 0001174947-26-000032 | | 2025-12-19 | 16:57 ET | [10-K](/filings/0001174947-25-001463.md) | Annual report, period 2025-09-27 | 0001174947-25-001463 | | 2025-08-28 | 17:25 ET | [8-K](/filings/0002077096-25-000085.md) | 5.02 Departure or appointment of officers or directors | 0002077096-25-000085 | | 2025-08-12 | 16:25 ET | [10-Q](/filings/0002077096-25-000008.md) | Quarterly report, period 2025-06-28 | 0002077096-25-000008 | | 2025-05-19 | 17:17 ET | [10-Q](/filings/0001174947-25-000783.md) | Quarterly report, period 2025-03-29 | 0001174947-25-000783 | ## Latest annual report [Form 10-K for the fiscal year ended Sep 27, 2025](/filings/0001174947-25-001463.md), filed Dec 19, 2025. ## Forecast league Q4 FY2026, the quarter ended 2026-09-27, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/7a63e0a1-36da-41d2-a3ed-aed2529a42c6) ## About the filer - CIK: 12040 - Tickers: BDL - Exchange: NYSE - SIC code: 5812 Retail-Eating Places - State of incorporation: FL - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.